Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Broto

Showing results (411-420 of 555) with videos related to

Pageof 56
Sort By:
Pharmaceutics|January 8, 2025
Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 ProtocolJuliana Salazar, María J Arranz, Javier Martin-Broto, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 22, 2023
Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk projectDavid Balayssac, Jérôme Busserolles, Catherine Broto, et al.
Clinical Orthopaedics and Related Research|August 24, 2022
Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVENJohn H Healey, William D Tap, Heather L Gelhorn, et al.
Rehabilitacion|June 2, 2024
[Relationship between frailty and functional status in lung transplant candidates]A Gómez-Garrido, B Planas-Pascual, P Launois, et al.
The Pediatric Infectious Disease Journal|September 14, 2022
Health and Vaccination Status of Unaccompanied Minors After Arrival in a European Border Country: A Cross-sectional Study (2017-2020)Clara Carreras-Abad, Inés Oliveira-Souto, Diana Pou-Ciruelo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on SarcomaRegina Alemany, David S Moura, Andres Redondo, et al.
Cellular and Molecular Life Sciences : CMLS|July 21, 2022
ISG15 as a prognostic biomarker in solitary fibrous tumourJose L Mondaza-Hernandez, David S Moura, María Lopez-Alvarez, et al.
Molecular Cancer Therapeutics|November 12, 2020
Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue SarcomaJavier Martín-Broto, Antonio López Pousa, Andrew S Brohl, et al.
Acta Orthopaedica|May 12, 2021
Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trialMichiel Van De Sande, William D Tap, Heather L Gelhorn, et al.
Cytokine|February 16, 2024
Circulating TNF-RII, IP-10 and HGF are associated with severity of COVID-19 in oncologic patientsJaime Carrillo-García, Serena Lacerenza, Nadia Hindi, et al.
Pageof 56

Showing results (411-420 of 555) with videos related to

Sort By:
Pageof 56
Pharmaceutics|January 8, 2025
Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 ProtocolJuliana Salazar, María J Arranz, Javier Martin-Broto, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 22, 2023
Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk projectDavid Balayssac, Jérôme Busserolles, Catherine Broto, et al.
Clinical Orthopaedics and Related Research|August 24, 2022
Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVENJohn H Healey, William D Tap, Heather L Gelhorn, et al.
Rehabilitacion|June 2, 2024
[Relationship between frailty and functional status in lung transplant candidates]A Gómez-Garrido, B Planas-Pascual, P Launois, et al.
The Pediatric Infectious Disease Journal|September 14, 2022
Health and Vaccination Status of Unaccompanied Minors After Arrival in a European Border Country: A Cross-sectional Study (2017-2020)Clara Carreras-Abad, Inés Oliveira-Souto, Diana Pou-Ciruelo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on SarcomaRegina Alemany, David S Moura, Andres Redondo, et al.
Cellular and Molecular Life Sciences : CMLS|July 21, 2022
ISG15 as a prognostic biomarker in solitary fibrous tumourJose L Mondaza-Hernandez, David S Moura, María Lopez-Alvarez, et al.
Molecular Cancer Therapeutics|November 12, 2020
Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue SarcomaJavier Martín-Broto, Antonio López Pousa, Andrew S Brohl, et al.
Acta Orthopaedica|May 12, 2021
Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trialMichiel Van De Sande, William D Tap, Heather L Gelhorn, et al.
Cytokine|February 16, 2024
Circulating TNF-RII, IP-10 and HGF are associated with severity of COVID-19 in oncologic patientsJaime Carrillo-García, Serena Lacerenza, Nadia Hindi, et al.
Pageof 56